Prognosis
CDC Panel Backs Moderna, J&J Boosters; Pfizer Data: Virus Update
This article is for subscribers only.
An advisory panel of the U.S. Centers for Disease Control and Prevention backed additional doses of the Moderna Inc. and Johnson & Johnson vaccines.
Pfizer Inc. and BioNTech SE said a booster shot of their inoculation restored full protection in a large study, bolstering the case for administering a third dose more widely. Meanwhile, the U.K. reported the most new cases since July.